Transmission and spreading of tauopathy in transgenic mouse brain

Cited by (1,006)

Items 901–1,000 of 1,006

1. Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics
   Aaron R. Ritter, Jeffrey L. Cummings · 2015 · Frontiers in Neurology
2. In Vivo Spreading of Tau Pathology
   Claudio A. Soto · 2012 · Neuron
3. Protein Misfolding in Prion and Prion-Like Diseases: Reconsidering a Required Role for Protein Loss-of-Function
   Patricia L.A. Leighton, W. Ted Allison · 2016 · Journal of Alzheimer s Disease
4. Visualization of soluble tau oligomers in TauP301L-BiFC transgenic mice demonstrates the progression of tauopathy
   Seulgi Shin, Do‐Hee Kim, Ji Yeon Song, Hyeanjeong Jeong, Seung Jae Hyeon, Neil W. Kowall, Hoon Ryu, Ae Nim Pae, Sungsu Lim, Yun Kyung Kim · 2020 · Progress in Neurobiology
5. Non-Rodent Genetic Animal Models for Studying Tauopathy: Review of Drosophila, Zebrafish, and C. elegans Models
   Hoi-Khoanh Giong, Manivannan Subramanian, Kweon Yu, Jeong-Soo Lee · 2021 · International Journal of Molecular Sciences
6. Mouse models of Alzheimer's disease for preclinical research
   Naoto Watamura, Kaori Sato, Takaomi C. Saido · 2022 · Neurochemistry International
7. Biochemical and strain properties of CJD prions: complexity versus simplicity
   Stéphane Haı̈k, Jean‐Philippe Brandel · 2011 · Journal of Neurochemistry
8. Tau seeds from Alzheimer's disease brains trigger tau spread in macaques while oligomeric‐Aβ mediates pathology maturation
   Morgane Darricau, Changsong Dou, Rémi Kinet, Tao Zhu, Li Zhou, Xianglei Li, Aurélie Bedel, Stéphane Claverol, Caroline Tokarski, Taxiarchis Katsinelos et al. · 2023 · Alzheimer s & Dementia
9. Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome
   Chaitali Anand, Farras Abdelnour, Benjamin S. Sipes, Daren Ma, Pedro D. Maia, Justin Torok, Ashish Raj · 2025 · Brain
10. Protein aggregation and prionopathies
    Marianne L. Renner, Ronald Melki · 2014 · Pathologie Biologie
11. Role of cellular prion protein in interneuronal amyloid transmission
    José Antonio del Rı́o, Isidró Ferrer, Rosalina Gavı́n · 2018 · Progress in Neurobiology
12. Role of tau N-terminal motif in the secretion of human tau by End Binding proteins
    Carmen Laura Sayas, Miguel Medina, Raquel Cuadros, Ivana Ollà, Esther García, Mar Pérez, Isidró Ferrer, Félix Hernández, Jesús Ávila · 2019 · PLoS ONE
13. Carbonic anhydrase inhibition ameliorates tau toxicity via enhanced tau secretion
    Ana López, Farah H. Siddiqi, Julien Villeneuve, Rodrigo Portes Ureshino, Hee-Yeon Jeon, Philippos Koulousakis, Sophie Keeling, William A. McEwan, Angeleen Fleming, David Chaim Rubinsztein · 2024 · Nature Chemical Biology
14. Cellular Biology of Tau Diversity and Pathogenic Conformers
    Sang‐Gyun Kang, Ghazaleh Eskandari‐Sedighi, Lenka Hromádková, Jiri Safar, David A. Westaway · 2020 · Frontiers in Neurology
15. Decrease of neuronal FKBP4/FKBP52 modulates perinuclear lysosomal positioning and MAPT/Tau behavior during MAPT/Tau-induced proteotoxic stress
    Béatrice Chambraud, Corentin Daguinot, Kevin Guillemeau, Mélanie Genet, Omar Dounane, Geri Méduri, Christian Poüs, E.E. Baulieu, Julien Giustiniani · 2021 · Autophagy
16. P62 accumulates through neuroanatomical circuits in response to tauopathy propagation
    François-Xavier Blaudin de Thé, Benjamin Lassus, Ari W. Schaler, Stephanie L. Fowler, Chris N. Goulbourne, Ross Jeggo, Clotilde Mannoury la Cour, Mark John Millan, Karen Duff · 2021 · Acta Neuropathologica Communications
17. PET Imaging in Animal Models of Alzheimer’s Disease
    Baosheng Chen, Bernadette V. Marquez-Nostra, Erika Belitzky, Takuya Toyonaga, Jie Tong, Yiyun Henry Huang, Zhengxin Cai · 2022 · Frontiers in Neuroscience
18. Aβ and tau prions feature in the neuropathogenesis of Down syndrome
    Carlo Condello, Alison M. Maxwell, Erika Castillo, Atsushi Aoyagi, Caroline Graff, Martin Ingelsson, Lars Lannfelt, Thomas D. Bird, Christopher Dirk Keene, William W. Seeley et al. · 2022 · Proceedings of the National Academy of Sciences
19. Pathological and physiological functional cross-talks of α-synuclein and tau in the central nervous system
    Mingyue Jin, Shengming Wang, Xiaodie Gao, Zhenyou Zou, Shinji Hirotsune, Liyuan Sun · 2023 · Neural Regeneration Research
20. The influence of APOEε4 on the pTau interactome in sporadic Alzheimer’s disease
    Manon Thierry, Jackeline Ponce, Mitchell Martá-Ariza, Manor Askenazi, Arline Faustin, Dominique Leitner, Geoffrey Pires, Evgeny Kanshin, Eleanor Drummond, Beatrix M. Ueberheide et al. · 2024 · Acta Neuropathologica
21. Clearance of amyloid β-protein and its role in the spreading of Alzheimer's disease pathology
    Dietmar Rudolf Thal · 2015 · Frontiers in Aging Neuroscience
22. Convergent molecular defects underpin diverse neurodegenerative diseases
    George K. Tofaris, Noel J. Buckley · 2018 · Journal of Neurology Neurosurgery & Psychiatry
23. Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis
    Stefan Bräuer, Vitaly L. Zimyanin, Andreas Hermann · 2018 · Journal of Neural Transmission
24. Inhibitory Effects of Isobavachalcone on Tau Protein Aggregation, Tau Phosphorylation, and Oligomeric Tau-Induced Apoptosis
    Shifeng Xiao, Qiuping Wu, Xuanbao Yao, Jiahao Zhang, Weicong Zhong, Junyi Zhao, Qiong Liu, Mohan Zhang · 2020 · ACS Chemical Neuroscience
25. Precision proteoform design for 4R tau isoform selective templated aggregation
    Andrew P. Longhini, Austin DuBose, Samuel Lobo, Vishnu Vijayan, Yeran Bai, Erica Keane Rivera, Julia Sala‐Jarque, Arina A. Nikitina, Daniel Carneiro Carrettiero, Matthew Unger et al. · 2024 · Proceedings of the National Academy of Sciences
26. Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins
    Hasier Eraña, Vanesa Venegas, Jorge M. Charco, Joaquı́n Castilla · 2016 · Biochemical and Biophysical Research Communications
27. Combined Model of Aggregation and Network Diffusion Recapitulates Alzheimer's Regional Tau-Positron Emission Tomography
    Ashish Raj, Veronica Tora, Xiao Gao, Hanna Cho, Jae Yong Choi, Young Hoon Ryu, Chul Hyoung Lyoo, Bruno Franchi · 2021 · Brain Connectivity
28. Cis P-tau is a central circulating and placental etiologic driver and therapeutic target of preeclampsia
    Sukanta Jash, Sayani Banerjee, Shi‐Bin Cheng, Bin Wang, Chenxi Qiu, Asami Kondo, Jan Ernerudh, Xiao Zhen Zhou, Kun Ping Lu, Surendra Sharma · 2023 · Nature Communications
29. The type‐I interferon response potentiates seeded tau aggregation and exacerbates tau pathology
    Sanford, Sophie A. I., Miller, Lauren V. C., Vaysburd, Marina, Keeling, Sophie, Tuck, Benjamin J., Clark, Jessica, Neumann, Michal, Syanda, Victoria, James, Leo C., McEwan, William A. · 2024 · Alzheimer's & Dementia
30. Isolation and characterization of antibody fragments selective for toxic oligomeric tau
    Huilai Tian, Eliot J. Davidowitz, Patricia Luciana da Costa Lopez, Ping He, Philip Schulz, James G. Moe, Michael R. Sierks · 2014 · Neurobiology of Aging
31. GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells
    Jonathan O. Speare, Danielle K. Offerdahl, Aaron M. Hasenkrug, Aaron Carmody, Gerald S. Baron · 2010 · The EMBO Journal
32. Visualization of prion-like transfer in Huntington's disease models
    Anne H. P. Jansen, Kevin Llewelyn Batenburg, Eline Pecho‐Vrieseling, Eric A. Reits · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
33. Layer-specific expression of extracellular matrix molecules in the mouse somatosensory and piriform cortices
    Hiroshi Ueno, Shunsuke Suemitsu, Shinji Murakami, Naoya Kitamura, Kenta Wani, Yosuke Matsumoto, Motoi Okamoto, Takeshi Ishihara · 2018 · IBRO Reports
34. A short perspective on the long road to effective treatments for Alzheimer's disease
    David S. Reynolds · 2019 · British Journal of Pharmacology
35. Photodynamic studies reveal rapid formation and appreciable turnover of tau inclusions
    Cara L. Croft, Marshall S. Goodwin, Daniel H. Ryu, Christian B. Lessard, Giancarlo Tejeda, Marc Marrero, Ava R. Vause, Giavanna Paterno, Pedro E. Cruz, Jada M. Lewis et al. · 2021 · Acta Neuropathologica
36. Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease—From Brain Starch to Bench and Bedside
    Pawlowski, Matthias, Meuth, Sven, Duning, Thomas · 2017 · Diagnostics
37. Microglia internalize tau monomers and fibrils using distinct receptors but similar mechanisms
    Kristian F. Falkon, Liliana Danford, Eduardo Gutierrez Kuri, Paulina Esquinca‐Moreno, Yaren L. Peña Señeriz, Sabrina A. Smith, Jessica L. Wickline, Ariel Louwrier, Jacob Alec McPhail, Naomi L. Sayre et al. · 2024 · Alzheimer s & Dementia
38. Proteasome inhibition induces stress kinase dependent transport deficits — Implications for Alzheimer's disease
    Lotta Agholme, Sangeeta Nath, Jakob Domert, Jan O. Marcusson, Katarina Kågedal, Martin Hallbeck · 2013 · Molecular and Cellular Neuroscience
39. Secretion of full-length tau or tau fragments in a cell culture model
    Mar Pérez, Raquel Cuadros, Félix Hernández, Jesús Ávila · 2016 · Neuroscience Letters
40. First-in-Rat Study of Human Alzheimer’s Disease Tau Propagation
    Tomáš Smolek, Santosh Jadhav, Veronika Brezováková, Veronika Cubinkova, Bernadeta Valachova, Petr Novák, Norbert Žilka · 2018 · Molecular Neurobiology
41. Astrogliopathy in Tauopathies
    Isidró Ferrer · 2018 · Neuroglia
42. Human subiculo-fornico-mamillary system in Alzheimer’s disease: Tau seeding by the pillar of the fornix
    Brainbank Neuro-CEB Neuropathology Network, Manon Thierry, Susana Boluda, Benoı̂t Delatour, Serge Marty, Danielle Seilhean, Marie‐Claude Potier, Charles J. Duyckaerts · 2019 · Acta Neuropathologica
43. Influence of traumatic brain injury on extracellular tau elimination at the blood–brain barrier
    Maxwell Eisenbaum, Andrew Pearson, Arissa Gratkowski, Benoit Mouzon, MICHAEL J. MULLAN, Fiona Crawford, Joseph O. Ojo, Corbin J. Bachmeier · 2021 · Fluids and Barriers of the CNS
44. Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
    Suzanne Lam, Anne‐Sophie Hérard, Susana Boluda, Fanny Petit, Sabiha Eddarkaoui, Karine Cambon, The Brainbank Neuro-CEB Neuropathology Network, Franck Letournel, Marie‐Laure Martin‐Négrier, Maxime Faisant et al. · 2022 · Acta Neuropathologica Communications
45. Gold nanoparticle-enhanced X-ray microtomography of the rodent reveals region-specific cerebrospinal fluid circulation in the brain
    Shelei Pan, Peter H Yang, Dakota DeFreitas, Sruthi Ramagiri, Peter O. Bayguinov, Carl D. Hacker, Abraham Z. Snyder, Jackson Wilborn, Hengbo Huang, Gretchen M. Koller et al. · 2023 · Nature Communications
46. The Role of Tissue Non-specific Alkaline Phosphatase (TNAP) in Neurodegenerative Diseases: Alzheimer’s Disease in the Focus
    Katherine A. B. Kellett, Nigel M. Hooper · 2015 · Sub-cellular biochemistry/Subcellular biochemistry
47. Significance and limitation of the pathological classification of TDP ‐43 proteinopathy
    Tetsuaki Arai · 2014 · Neuropathology
48. Functional diversity of protein fibrillar aggregates from physiology to RNA granules to neurodegenerative diseases
    Yoshiaki Furukawa, Nobuyuki Nukina · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
49. The Involvement of Cholinergic Neurons in the Spreading of Tau Pathology
    Diana Simón, Félix Hernández, Jesús Avila · 2013 · Frontiers in Neurology
50. Infectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like Mechanism
    Natalia Fernández‐Borges, Hasier Eraña, Saioa R. Elezgarai, Chafik Harrathi, Mayela Gayosso, Joaquı́n Castilla · 2013 · International Journal of Cell Biology
51. Prelysosomal Compartments in the Unconventional Secretion of Amyloidogenic Seeds
    Helena Borland Madsen, Frederik Vilhardt · 2017 · International Journal of Molecular Sciences
52. Mechanistic and Structural Origins of the Asymmetric Barrier to Prion-like Cross-Seeding between Tau-3R and Tau-4R
    Harish Kumar, Jayant B. Udgaonkar · 2018 · Journal of Molecular Biology
53. The Quest for Cellular Prion Protein Functions in the Aged and Neurodegenerating Brain
    Rosalina Gavı́n, Laia Lidón, Isidró Ferrer, José Antonio del Rı́o · 2020 · Cells
54. BAG3 Regulation of RAB35 Mediates the Endosomal Sorting Complexes Required for Transport/Endolysosome Pathway and Tau Clearance
    Heng Lin, Maoping Tang, Changyi Ji, Peter Girardi, Gregor Cvetojevic, Daniel Chen, Shon A. Koren, Gail V.W. Johnson · 2021 · Biological Psychiatry
55. Protein aggregates stimulate macropinocytosis facilitating their propagation
    Justin J. Yerbury · 2016 · Prion
56. Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice
    Zhiva Kalinova Skachokova, Alfonso Martinisi, Martin Flach, Frederik Sprenger, Yvonne Naegelin, Viviane Steiner-Monard, Marc A. Sollberger, Andreas Urs Monsch, Michel Goedert, Markus Tolnay et al. · 2019 · Acta Neuropathologica Communications
57. Early Electrophysiological Disintegration of Hippocampal Neural Networks in a Novel Locus Coeruleus Tau-Seeding Mouse Model of Alzheimer’s Disease
    Abdallah Ahnaou, Callum Walsh, Nikolay V. Manyakov, Sameh A. Youssef, Wilhelmus H. I. M. Drinkenburg · 2019 · Neural Plasticity
58. Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates
    Helen Ling, Ellen Gelpí, Karen Davey, Zane Jaunmuktane, Kin Ying Mok, Edwin Jabbari, Roberto Simone, Lea R’Bibo, Sebastian Brandner, Matthew J. Ellis et al. · 2020 · Acta Neuropathologica
59. Recent advances in tau-directed immunotherapy against Alzheimer’s disease: an overview of pre-clinical and clinical development
    Pei Ying Ng, I Shuen Chang, Rhun Yian Koh, Soi Moi Chye · 2020 · Metabolic Brain Disease
60. Structural and functional damage to neuronal nuclei caused by extracellular tau oligomers
    Xuehan Sun, Guillermo Eastman, Yu Shi, Subhi Saibaba, Ana K. Oliveira, John R. Lukens, Andrés Norambuena, Joseph A. Thompson, Michael D. Purdy, Kelly A. Dryden et al. · 2023 · Alzheimer s & Dementia
61. DNAJB8 oligomerization is mediated by an aromatic-rich motif that is dispensable for substrate activity
    Bryan D. Ryder, Elizaveta Ustyantseva, David R. Boyer, Aydé Mendoza‐Oliva, Mikołaj I. Kuska, Paweł M. Wydorski, Paulina Macierzyńska, Nabil Morgan, Michael R. Sawaya, Marc I. Diamond et al. · 2024 · Structure
62. Death or secretion? The demise of a plausible assumption about CSF-tau in Alzheimer Disease?
    Garth F. Hall, Sudad Saman · 2012 · Communicative & Integrative Biology
63. Neuron-to-Neuron Transmission of Neurodegenerative Pathology
    Martin Hallbeck, Sangeeta Nath, Jan O. Marcusson · 2013 · The Neuroscientist
64. Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease
    Robert Y. K. Lai, Charles R. Harrington, Claude M. Wischik · 2016 · Biomolecules
65. Abolishing Tau cleavage by caspases at Aspartate421 causes memory/synaptic plasticity deficits and pre-pathological Tau alterations
    Fabrizio Biundo, Cristina d’Abramo, Marc D. Tambini, H Zhang, Dolores Del Prete, Francesca Vitale, Luca Giliberto, Ottavio Arancio, Luciano D'adamio · 2017 · Translational Psychiatry
66. Exosomes as Possible Spread Factor and Potential Biomarkers in Alzheimer'S Disease: Current Concepts
    Ryszard M. Pluta, Marzena Ułamek-Kozioł, Sławomir Januszewski, Stanisław Jerzy Czuczwar · 2018 · Biomarkers in Medicine
67. Traumatic Brain Injury-related voiding dysfunction in mice is caused by damage to rostral pathways, altering inputs to the reflex pathways
    Önder Albayram, Bryce MacIver, John Mathai, Anne M.J. Verstegen, Sean Baxley, Chenxi Qiu, Carter A. Bell, Barbara J. Caldarone, Xiao Zhen Zhou, Kun Ping Lu et al. · 2019 · Scientific Reports
68. Development of immunoprecipitation – two-dimensional liquid chromatography – mass spectrometry methodology as biomarker read-out to quantify phosphorylated tau in cerebrospinal fluid from Alzheimer disease patients
    Sebastiaan Bijttebier, Clara Theunis, Farid Jahouh, Dina Rodrigues Martins, Marc Verhemeldonck, Karolien Grauwen, Lieve Dillen, Marc H. Mercken · 2021 · Journal of Chromatography A
69. Lesion of the subiculum reduces the spread of amyloid beta pathology to interconnected brain regions in a mouse model of Alzheimer’s disease
    George, Sonia, Rönnbäck, Annica, Gouras, Gunnar K, Petit, Géraldine H, Grueninger, Fiona, Winblad, Bengt, Graff, Caroline, Brundin, Patrik · 2014 · Acta Neuropathologica Communications
70. A High-Throughput Screening Assay for Determining Cellular Levels of Total Tau Protein
    Seameen Dehdashti, Wei Zheng, Joel R. Gever, Robert S. Wilhelm, Ðắc-Trung Nguyễn, Gurusingham Sitta Sittampalam, John C. McKew, Christopher P. Austin, Stanley B. Prusiner · 2013 · Current Alzheimer Research
71. Neurodegenerative lesions: Seeding and spreading
    Charles J. Duyckaerts · 2013 · Revue Neurologique
72. Nanotechnology for tau pathology in Alzheimer's disease
    Rongrong Ma, Qianwen Mu, Yue Xi, Gang Liu, Chao Liu · 2024 · Materials Today Bio
73. Does Anticholinergic Activity Affect Neuropathology Implication of Neuroinflammation in Alzheimer's Disease
    Yoshiyama, Yasumasa, Kojima, Ayako, Itoh, Kimiko, Isose, Sagiri, Koide, Mizuho, Hori, Koji, Arai, Kimihito · 2015 · Neurodegenerative Diseases
74. Is there a significant interaction effect between apolipoprotein E rs405509 T/T and ε4 genotypes on cognitive impairment and gray matter volume?
    Cheng Ma, Y. Zhang, X. Li, Jing Zhang, K. Chen, Ying Liang, Yaojing Chen, Z. Liu, Z. Zhang · 2016 · European Journal of Neurology
75. Targeting Tau to Treat Clinical Features of Huntington's Disease
    Maria Masnata, Shireen Salem, Aurélie de Rus Jacquet, Mehwish Anwer, Francesca Cicchetti · 2020 · Frontiers in Neurology
76. Novel chemical inhibitor against SOD1 misfolding and aggregation protects neuron-loss and ameliorates disease symptoms in ALS mouse model
    Tae‐Gyun Woo, Min-Ho Yoon, So‐mi Kang, So‐Young Park, Jung-Hyun Cho, Young Jun Hwang, Jinsook Ahn, Hyewon Jang, Yun-Jeong Shin, Eui‐Man Jung et al. · 2021 · Communications Biology
77. Proteolytic clearance of extracellular α-synuclein as a new therapeutic approach against Parkinson disease
    Sang Myun Park, Kwang Soo Kim · 2013 · Prion
78. Tau Oligomers
    Maeda, Sumihiro, Takashima, Akihiko · 2019 · Advances in Experimental Medicine and Biology
79. The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition
    Eskandari-Sedighi, Ghazaleh, Daude, Nathalie, Gapeshina, Hristina, Sanders, David W., Kamali-Jamil, Razieh, Yang, Jing, Shi, Beipei, Wille, Holger, Ghetti, Bernardino, Diamond, Marc I. et al. · 2017 · Molecular Neurodegeneration
80. Nanobiotechnology in Neurodegenerative Diseases
    Josef Jampílek, Katarína Kráľová, Petr Novák, Michal Novák · 2019 · Springer eBooks
81. Paired Helical Filament-Forming Region of Tau (297–391) Influences Endogenous Tau Protein and Accumulates in Acidic Compartments in Human Neuronal Cells
    Saskia J. Pollack, Jasmine E Trigg, Tahmida Khanom, Luca Biasetti, Karen E. Marshall, Youssra K. Al‐Hilaly, Janet E. Rickard, Charles R. Harrington, Claude M. Wischik, Louise C. Serpell · 2020 · Journal of Molecular Biology
82. Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer’s Disease
    Amy R. Nelson · 2022 · Frontiers in Aging Neuroscience
83. Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice
    Shuai Zhao, Ziqi Fan, Xinyi Zhang, Zheyu Li, Ting Shen, Kaicheng Li, Yaping Yan, Yunfeng Yuan, Jiali Pu, Jun Tian et al. · 2022 · Neurotherapeutics
84. Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease
    Dmitry V. Eremin, Elena M. Kondaurova, Aleksander Ya Rodnyy, Camilla A. Molobekova, Dmitry Anatolievich Kudlay, Vladimir S. Naumenko · 2023 · Biochemistry (Moscow)
85. Detecting tau in serum of transgenic animal models after tau immunotherapy treatment
    Cristina d’Abramo, Christopher M. Acker, Joel B. Schachter, Giuseppe Terracina, Xiaohai Wang, Stefanie K. Forest, Peter Davies · 2015 · Neurobiology of Aging
86. The Brain’s Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer’s Disease
    Sneha Pandya, Alzheimer’s Disease Neuroimaging Initiative, Amy F. Kuceyeski, Ashish Raj · 2016 · Journal of Alzheimer s Disease
87. Extracellular Vesicles as a Source of Urological Biomarkers: Lessons Learned From Advances and Challenges in Clinical Applications to Major Diseases
    Ji‐Young Choi, Sujin Kim, Hyo‐Bum Kwak, Dong‐Ho Park, Jae‐Hyoung Park, Jeong‐Seon Ryu, Chang‐Shin Park, Ju‐Hee Kang · 2017 · International Neurourology Journal
88. Is it Useful to Classify PSP and CBD as Different Disorders? Yes
    Helen Ling, Antonella Macerollo · 2017 · Movement Disorders Clinical Practice
89. Inactivation Methods for Prions
    Akikazu Sakudo · 2019 · Current Issues in Molecular Biology
90. Differential accumulation of Tau phosphorylated at residues Thr231, Ser262 and Thr205 in hippocampal interneurons and its modulation by Tau mutations (VLW) and amyloid-β peptide
    Eva Dávila-Bouziguet, Georgina Targa Fabra, Jesús Ávila, Eduardo Soriano, Marta Pascual · 2018 · Neurobiology of Disease
91. Tau Is Involved in Death of Retinal Ganglion Cells of Rats From Optic Nerve Crush
    Hidehiro Oku, Teruyo Kida, Taeko Horie, Koichiro Taki, Masashi Mimura, Shota Kojima, Tsunehiko Ikeda · 2019 · Investigative Ophthalmology & Visual Science
92. Seeding Activity-Based Detection Uncovers the Different Release Mechanisms of Seed-Competent Tau Versus Inert Tau via Lysosomal Exocytosis
    Yuki Tanaka, Kaoru Yamada, Kyoko Satake, Itaru Nishida, Matthias Heuberger, Tomoki Kuwahara, Takeshi Iwatsubo · 2019 · Frontiers in Neuroscience
93. Self‐Therapeutic Nanoparticle That Alters Tau Protein and Ameliorates Tauopathy Toward a Functional Nanomedicine to Tackle Alzheimer's
    Sunil Kumar Vimal, Hua Zuo, Zhengwu Wang, Hongrun Wang, Zhiliang Long, Sanjib Bhattacharyya · 2020 · Small
94. Tau assemblies do not behave like independently acting prion-like particles in mouse neural tissue
    Aamir S. Mukadam, Lauren V. C. Miller, Claire S. Durrant, Marina J. Vaysburd, Taxiarchis Katsinelos, Benjamin J. Tuck, Sophie Sanford, Olivia Sheppard, Claire Knox, Shi Cheng et al. · 2021 · Acta Neuropathologica Communications
95. Tau Secretion
    Zhi Ruan, Tsuneya Ikezu · 2019 · Advances in experimental medicine and biology
96. Secrets of the shaking palsy
    Jim Schnabel · 2010 · Nature
97. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model
    Kunié Ando, Karelle Leroy, Céline Héraud, Anna Kabova, Zehra Yilmaz, Michèle Authelet, Valérie Suain, Robert De Decker, Jean‐Pierre Brion · 2010 · Biochemical Society Transactions
98. Cellular Models for the Study of Prions
    Brandon B. Holmes, Marc I. Diamond · 2016 · Cold Spring Harbor Perspectives in Medicine
99. Retromer dysfunction at the nexus of tauopathies
    Carosi, Julian M., Denton, Donna, Kumar, Sharad, Sargeant, Timothy J. · 2021 · Cell Death & Differentiation
100. A review of proposed mechanisms for neurodegenerative disease
     Kelser, Benjamin M., Teichner, Eric M., Subtirelu, Robert C., Hoss, Kevin N. · 2024 · Frontiers in Aging Neuroscience